Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

Infusion of Venofundin 6% or Tetraspan 6% in Paediatric Patients Aged up to 12 Years

This observational (non-interventional) post-authorization safety study (PASS) will investigate the application of Venofundin 6% and of Tetraspan 6% in children with special regard to drug safety.

Inclusion Criteria:

• Age ≤12 years
• Risk of anaesthesia: American Society of Anaesthesiologists (ASA) risk score: I - III
• infusion of Venofundin 6% or of Tetraspan 6%
• elective intervention

Exclusion Criteria:

• contraindications according to SmPC